Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Etofylline clofibrate has a hypolipidemic and antithrombotic effect and it also has an agonistic interaction with intimal PGI2.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 5 days | $ 48.00 | |
5 mg | 5 days | $ 76.00 | |
1 mL * 10 mM (in DMSO) | 5 days | $ 107.00 |
Description | Etofylline clofibrate has a hypolipidemic and antithrombotic effect and it also has an agonistic interaction with intimal PGI2. |
In vivo | Etofylline clofibrate administered orally at a dosage of 12 mg/kg demonstrates a moderate initial efficacy with a 12% reduction in disaggregation time from a single dose. The effectiveness of the compound increases significantly with consistent daily usage, achieving a maximum reduction in disaggregation time of 31% after 5 days and 43% after 7 days of consecutive applications. |
Molecular Weight | 420.85 |
Formula | C19H21ClN4O5 |
CAS No. | 54504-70-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 52 mg/mL (123.56 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Etofylline clofibrate 54504-70-0 Others inhibitor inhibit